Newsroom

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), une société biopharmaceutique en phase clinique développant des traitements innovants pour des maladies chroniques graves à physiopathologie métabolique, notamment la stéatohépatite associée à un dysfonctionnement métabolique (MASH) et les maladies métaboliques rares, annonce la mise à disposition par IRIS d’un financement (dit « SmartATM® ») d’un montant maximum de 5 millions d’euros sur 5 ans (dont les...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, announces the implementation of an equity line with IRIS, known as “SmartATM® “ for a maximum amount of €5 million over five years (terms set out in the Appendix without this...

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Arkema (Paris:AKE), a global leader in Specialty Materials, and Senior, a global leader in battery separators technologies, have signed a Memorandum of Understanding (MoU) to further strengthen their long-term strategic cooperation and jointly advance innovation across the battery value chain. Under this strategic collaboration, Arkema and Senior will deepen their technical, commercial, and application-focused cooperation related to Arkema’s c...

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Arkema (Paris:AKE), un leader mondial des Matériaux de Spécialités, et Senior, un leader mondial des technologies de séparateurs pour batteries, ont signé un protocole d'accord afin de renforcer davantage leur coopération stratégique à long terme et de faire progresser ensemble l’innovation tout au long de la chaîne de valeur des batteries. Dans le cadre de cette collaboration stratégique, Arkema et Senior renforceront leur coopération techniq...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--DATROWAY Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy...

MIRAMAR, Fla.--(BUSINESS WIRE)--VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services, announced today that it has priced its previously announced underwritten public offering of 3,989,362 shares of its common stock at a price to the public of $188.00 per share, representing approximately $750 million of shares of common stock, and its previously announced concurrent underwritten public offering of 8,000,000 of its 5...

VÉLIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Castles Technology successfully acquires MT Bilgi Teknolojileri A.Ş. (MTBT)....

OMAHA, Neb. & LONDON--(BUSINESS WIRE)--Annual refund volumes in the global retail sector increased 18.1 % in 2025, while refund value rose 12.7% year-on-year, according to ACI’s annual Global Ecommerce Report. ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, analysed billions of retail transactions worldwide as part of the study. Refund activity peaked sharply during the holiday season; November and December together accounted for approximately 20% of all refun...

東京--(BUSINESS WIRE)--（ビジネスワイヤ） -- 3D Investment Partners Pte. Ltd.（以下「当社」）は、東邦ホールディングス株式会社（以下「東邦HD」）より2026年1月23日に受領した大規模買付行為等に係る「本必要情報の提供の要請」に対し、本日、回答書を提出いたしました。 また、併せて、2026年1月29日付で東邦HDの指名報酬委員会及び社外取締役に対し、次期CEO指名プロセスに関する書簡を送付しましたので、これらを公開いたします。 当社は、本回答書について、東邦HDの株主の皆様に以下の重要事項をご理解いただきたく存じます。 1. 買収防衛策の対象にはなり得ないこと（架空の有事） 当社は、東邦HDの経営支配権の獲得を目的としておらず、純投資及び状況に応じて経営陣への助言・重要提案行為を行う目的で一貫しております。 その証左として、2025年7月11日付け東邦HD宛書簡により経営支配権の獲得を目的としていないことを明確に伝えたほか、2025年8月8日時点で「議決権割合の上限を30%以下とする」旨の誓約書案を提出しており、さらに今般の追加...

LONDON--(BUSINESS WIRE)--  The issuer advises that the following replaces the Young & Co's Brewery PLC Transaction in Own Shares announcement released at 07:00 GMT on 02/02/2026 to correctly reflect the Transaction price of the trade at 13:49:57 on 30 January 2026 and the resultant volume-weighted average price for that day. All other details remain unchanged. The full corrected version is shown below. 02 February 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young &...